Advantage Alpha Capital Partners LP Sells 22,168 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Advantage Alpha Capital Partners LP reduced its position in HealthEquity, Inc. (NASDAQ:HQY) by 21.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 83,092 shares of the company’s stock after selling 22,168 shares during the quarter. HealthEquity comprises about 1.5% of Advantage Alpha Capital Partners LP’s portfolio, making the stock its 15th largest position. Advantage Alpha Capital Partners LP owned about 0.10% of HealthEquity worth $6,801,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. International Assets Investment Management LLC acquired a new stake in HealthEquity in the second quarter valued at about $35,000. Paladin Wealth LLC bought a new position in shares of HealthEquity in the third quarter worth about $39,000. GAMMA Investing LLC boosted its stake in shares of HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after purchasing an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of HealthEquity during the 2nd quarter valued at approximately $73,000. Finally, 1620 Investment Advisors Inc. acquired a new position in HealthEquity during the 3rd quarter worth approximately $112,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 10,536 shares of company stock valued at $884,517 over the last 90 days. Company insiders own 2.20% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on HQY shares. Barrington Research reaffirmed an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. The Goldman Sachs Group assumed coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective on the stock. JMP Securities reiterated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. BTIG Research boosted their price target on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $107.23.

HealthEquity Stock Down 0.5 %

Shares of NASDAQ HQY opened at $103.76 on Tuesday. The company’s 50 day moving average price is $87.74 and its 200-day moving average price is $81.95. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $105.82. The company has a market capitalization of $9.06 billion, a P/E ratio of 86.47, a price-to-earnings-growth ratio of 1.63 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. Equities analysts forecast that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.